A phase 3 clinical trial evaluating efficacy and safety of febuxostat in cancer chemotherapy patients with malignant tumors.
Phase of Trial: Phase III
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Febuxostat (Primary)
- Indications Tumours
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2016 New trial record